CRISPR/Cas9 technology generated a one nucleotide substitution in the initiation codon, ATG to ATT. This is a variant identified in a patient with epidermolysis bullosa. (J:327299)
查看原文 参与反馈
CRISPR/Cas9 technology generated a one nucleotide substitution in the initiation codon, ATG to ATT. This is a variant identified in a patient with epidermolysis bullosa. (J:327299)